Should lebrikizumab be used as monotherapy, or can it be combined with other treatments?

Featuring Raj Chovatiya, MD, PhD, MSCI | Associate Professor, Rosalind Franklin University of Medicine and Science, Chicago Medical School; Founder and Director,Center for Medical Dermatology + Immunology Research,Chicago, IL | Published December 02, 2024